Track Record of Identifying Rare Wealth CreatorsTrack Record of Identifying Rare Wealth Creators

Your blog category

August 10, 2026
The last mile: the road from the factory to the village shelf, and why distribution reach is one of the hardest advantages in business to copy

The Last Mile: Why Getting to the Shop Shelf Is One of India’s Quietest Moats

A great product nobody can find loses to an ordinary product that is everywhere. A plain-English lesson on distribution reach — the quiet, slow-built advantage that separates durable Indian businesses from the rest.
August 9, 2026
The owner's chair: the quiet rights that come with a single share — a row of chairs at the owners' table, one of them yours

The Owner’s Chair: The Quiet Rights That Come With a Single Share

A share is not a ticket with a blinking price. It is a chair at the owners' table — with a report addressed to you, a vote that counts, a dividend that pays you, and a voice that lets you ask. A plain-English lesson on the quiet rights that come with a single share.
August 8, 2026
The cook and the tiffin service: Benjamin Graham's two kinds of investor — the defensive road, the enterprising road, and the muddy middle to avoid

The Cook and the Tiffin Service: Benjamin Graham’s Two Kinds of Investor

Before you ask which share, answer Benjamin Graham's older question: which kind of investor am I? A plain-English lesson on the defensive road, the enterprising road, and the muddy middle to avoid.
August 4, 2026
Poster-style image claiming Titan Biotech Ltd gained +650% since Aug 2023 (BSE 524717), by Manish Goel; time-stamped analysis.

Why I Bought Titan Biotech — and Why It’s Up ~650% in 3 Years

On 4 August 2023 I posted publicly that I had bought Titan Biotech (BSE 524717). Three years on it is up roughly 650%. Here is the thesis behind the buy.
+91-8448836436